SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001214659-23-014554
Filing Date
2023-11-03
Accepted
2023-11-03 17:25:26
Documents
11

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 13 j113232sc13da13.htm SC 13D/A 51195
2 EXHIBIT 11 ex11.htm EX-11 15382
3 GRAPHIC ex11-001.jpg GRAPHIC 114095
4 GRAPHIC ex11-002.jpg GRAPHIC 27807
5 GRAPHIC ex11-003.jpg GRAPHIC 107439
6 GRAPHIC ex11-004.jpg GRAPHIC 100114
7 GRAPHIC ex11-005.jpg GRAPHIC 90964
8 GRAPHIC ex11-006.jpg GRAPHIC 89540
9 GRAPHIC ex11-007.jpg GRAPHIC 46039
10 GRAPHIC ex11-008.jpg GRAPHIC 79737
11 GRAPHIC ex11-009.jpg GRAPHIC 30701
  Complete submission text file 0001214659-23-014554.txt   1014443
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Subject) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-86428 | Film No.: 231377428
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8581 SANTA MONICA BLVD LOS ANGELES CA 90069
Business Address
William Anderson Wittekind (Filed by) CIK: 0001753085 (see all company filings)

Type: SC 13D/A